Science Market Update

UPENN Most Actively Funded Research Projects List

Posted by BCI Staff on Thu, Mar 01, 2018

 Are you looking to connect with the most active research projects on the U Penn Campus  this year?  See  table below:

BioResearch Product Faire™ Event at
The University of Pennsylvania

Join us on May 10, 2018

 

U PENN is NOW a $942 Million Research Marketplace 

Key Stats:

  • 2016 Life Science R & D Expenditures: 2nd Ranked = $942,243,000.

  • The NIH awarded UPenn $478,866,008 in total life science research funding in 2016.
  • A $27 million Center for Advanced Cellular Therapies recently opened at the UPenn Medical Campus. 24,000 sqft of the facility will be dedicated to research laboratories and cell therapy manufacturing.

  • The University of Pennsylvania received a $24 million, five-year, grant to establish a Science and Technology Center (STC) focused on researching the way cells exert and are influenced by the physical forces in their environment.
  • Jon & Mindy Grey gifted $21 million to the Basser Center for BRCA at Penn's Abramson Cancer Center. 

University of Pennsylvania, Philadelphia
Click to see past University of Pennsylvania photo gallery

 


"were able to meet both current contacts and future prospective contacts in the biotech world. As a small company dealing mostly with a very specific product list, this faire has been very helpful with our business because of the diverse array of exhibits. We definitely look forward to participating as an exhibitor in the future. 

At this event you can meet with researchers that are working in the following well funded programs:

PENN INTEGRATED HUMAN PANCREAS PROCUREMENT AND ANALYSIS PROGRAM NIDDK $12,249,589
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD NCATS $9,961,031
ABRAMSON CANCER CENTER SUPPORT GRANT NCI $6,945,078
ALZHEIMER'S DISEASE GENETICS CONSORTIUM NIA $4,265,776
HETEROGENEITY OF MULTI-MODAL IMAGING SIGNATURES OF AGING; MCI; ALZHEIMER'S DISEASE VIA PATTERN ANALYSIS NIA $3,791,182
UPENN TCORS: TOBACCO PRODUCT MESSAGING IN A COMPLEX COMMUNICATION ENVIRONMENT NCI $3,703,737
PERSONALIZATION OF THERAPEUTIC EFFICACY AND RISK NHLBI $3,666,137
SHIV/HIV ENV-ANTIBODY COEVOLUTION AS A GUIDE TO ITERATIVE VACCINE DESIGN NIAID $3,342,300
SHORT SLEEP: LOCUS COERULEUS METABOLICS AND THE TEMPORAL PROGRESSION OF ALZHEIMERS NIA $3,136,625
ENGINEERING T CELLS TO PROVIDE DURABLE CONTROL OF HIV-1 REPLICATION NIAID $2,951,367
CENTER FOR AIDS RESEARCH NIAID $2,946,696
INTEGRATED TARGET DISCOVERY IN ALZHEIMER'S DISEASE NIA $2,945,840
ENHANCING CHIMERIC ANTIGEN RECEPTOR T CELL THERAPIES FOR HEMATOLOGIC MALIGNANCIES: BEYOND CART 19 NCI $2,897,444
MOLECULAR MECHANISMS AND CELLULAR IMPLICATIONS OF TAU DYSFUNCTION NIA $2,739,985
IPSC-BASED PLATFORM DEVELOPMENT FOR MAJOR PSYCHIATRIC DISORDER MODELING AND DISCOVERY NIMH $2,643,131
CHANGING THE TRAJECTORY OF MILD COGNITIVE IMPAIRMENT WITH CPAP TREATMENT OF OBSTRUCTIVE SLEEP APNEA NIA $2,514,739
PLATELET SIGNALS AND THEIR INTERFACE WITH THE EXTERNAL ENVIRONMENT NHLBI $2,434,305
CHARTING OXYGEN-SENSING GENE REGULATORY NETWORK IN CARDIOMYOCYTES THROUGH SINGLE-CELL ANALYSIS AND EPIGENOME EDITING NHLBI $2,415,000
INDIVIDUAL DIFFERENCES IN OBSTRUCTIVE SLEEP APNEA NHLBI $2,359,665
FRONTOTEMPORAL DEMENTIAS: GENOTYPES AND PHENOTYPES NIA $2,337,667
RADIATION AND CHECKPOINT BLOCKADE FOR CANCER IMMUNE THERAPY NCI $2,329,233
ROLE OF SINGLE CELL MRNA VARIATION IN SYSTEMS ASSOCIATED ELECTRICALLY EXCITABLE C NIMH $2,311,889
PRIMARY OPEN ANGLE AFRICAN-AMERICAN GLAUCOMA GENETICS (POAAGG) NEI $2,236,160
ASBESTOS FATE; EXPOSURE; REMEDIATION; AND ADVERSE HEALTH EFFECTS NIEHS $2,204,665
COORDINATING CENTER FOR GENETICS AND GENOMICS OF ALZHEIMER'S DISEASE (CGAD) NIA $2,197,709
MEDICAL SCIENTIST TRAINING PROGRAM NIGMS $2,186,781
AAV GENE THERAPY FOR LIPID DISORDERS NHLBI $2,167,240
REGULATION OF PLATELET AND ENDOTHELIAL CELL FUNCTION NHLBI $2,152,449
DEVELOPMENTAL TRAJECTORIES OF NEGATIVE SYMPTOMS IN SCHIZOPHRENIA NIMH $2,103,262
LIVER CANCER: PRE-MALIGNANT STIFFENING; MEMBRANE TRANSDUCTION; & NUCLEAR RHEOLOGY NCI $2,076,805
LEARNING AND DECISION-MAKING IN HEALTHY AGING AND PRECLINICAL ALZHEIMER'S DISEASE NIA $2,012,500

Click this button to  get the  most recent funding stats delivered to your in box

Get UCLA funding stats

Click the button below to find out more about exhibiting at this event:

UPenn Exhibitors click here

 

Want more blogs like this? Click the button below:

Subscribe for Updates

IMG_1371.jpgIMG_6428.jpg

 

Tags: Pennsylvania, University of Pennsylvania, UPenn

Subscribe to Company News